Computational & Systems Biology Immunology

Size: px
Start display at page:

Download "Computational & Systems Biology Immunology"

Transcription

1 Computational & Systems Biology Immunology UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE RETREAT 2017 June 7, 2017 Twentieth Century Club

2 Highlights Keynote Address Steve Kleinstein, Ph.D. 8:40 AM - 9:40 AM ( ) Associate Professor of Pathology Yale University School of Medicine Faculty Talks 9:40 AM - 11:30 AM (morning session) 1:30 PM - 3:10 PM (afternoon session) See attached title list (see page 4). Round Tables 11:30 AM - 12:30 PM Round Table Discussion 2nd fl Lecture Hall 12:30 PM - 1:30 PM Meet the Expert Round tables Poster Session Odd Posters: 3:10 PM - 4:00 PM Even Posters: 4:00 PM - 5:00 PM See attached title list (see page 6). (Light bites will be provided) 2

3 Morning Session 8:30 AM - 8:40 AM 8:40 AM - 9:40 AM 9:40 AM - 10:00 AM 10:00 AM- 10:20 AM 10:20 AM - 10:30 AM 10:30 AM - 10:50 AM 10:50 AM - 11:10 AM 11:10 AM - 11:30 AM 11:30 AM - 12:30 PM 12:30 PM - 1:30 PM Afternoon Session 1:30 PM - 1:50 PM 1:50 PM - 2:10 PM 2:10 PM - 2:30 PM 2:30 PM - 2:50 PM 2:50 PM - 3:10 PM 3:00 PM - 5:00 PM 5:00 PM - 5:30 PM Welcome/Opening remarks (Ivet Bahar and Mark Shlomchik) Keynote - Dr. Steve Kleinstein Anne-Ruxandra Carvunis (CSB) Bill Hawse (Immuno) Coffee Break Takis Benos (CSB) Lisa Borghesi (Immuno) Carlos Camacho (CSB) Transition to round tables Round table discussion Lunch Break / Round tables Meet the Expert round tables Florian Weisel (Immuno) Chakra Chennubhotla (CSB) Sandra Cascio (Immuno) Jim Faeder (CSB) Dario Vignali (Immuno) Transition to poster session Poster Session Reception Awards and Closing Remarks 2nd fl Lecture Hall 1st fl Ballroom 1st fl Ballroom 3

4 Titles Talks Anne-Ruxandra Carvunis Assistant Professor, Computational & Systems Biology Of mice, men, network modeling and immune systems Bill Hawse Research Assistant Professor, Immunology Proteomic profiling identifies novel kinase signaling networks that drive T cell differentiation Takis Benos Professor, Computational & Systems Biology Causal modeling and its application to various disease/problems Lisa Borghesi Associate Professor, Immunology Constructing a Human B Cell Atlas using Computational Flow Cytometry and Unsupervised Approaches Carlos Camacho Associate Professor, Computational & Systems Biology How the immune system recognizes foreignness 4

5 Florian Weisel Research Assistant Professor, Immunology Memory B cell recall responses Chakra Chennubhotla Associate Professor, Computational & Systems Biology Computational spatial tumor pathology for phenotyping and immunotyping tumor microenvironments Sandra Cascio Research Assistant Professor, Immunology Validation of hypoglycosylated MUC1-CIN85 protein-protein interaction as a new therapeutic target for prevention of cancer invasion and metastasis Jim Faeder Associate Professor, Computational & Systems Biology Systems biology modeling of immune pathways Dario Vignali Professor, Immunology Single cell RNAseq analysis of immune populations in cancer 5

6 Posters 1. Andreas Vogt A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Causes Apoptosis, Enhances Lymphokine-Activated Killer Cell Activity and Activates Peripheral Blood Mononuclear Cells 2. Shu Wang Systematic association analysis of immune checkpoint blockade of PD -1 by RNA-seq data in advanced melanoma patients 3. Dimitrios Manatakis Causal Discovery on Pulmonary Hypertension Mixed Datasets 4. Tian Du Gene Expression Analysis Reveals Unique Immune Response in Invasive Lobular Breast Carcinoma 5. Jingyu Zhang Cells Interpret Temporal Information From TGF-β Through A Nested Relay Mechanism. 6. Deepali Sawant Regulatory T cell-derived inhibitory cytokines, IL35 and IL10, induce expression of multiple inhibitory receptors on tumor-infiltrating T cells 7. Bing Liu Systems-level Insights into Immune Regulation from Quantitative Modeling 8. Henry Ma Evaluation of Electrocardiography for Determing Diseasea nd Outcome Following aerosol Infection of Macaques with Equine Encephalitis Viruses 9. Hongchun Li Dynamic Modulation of Binding as a Mechanism for Regulating Interferon Signaling 6

7 10. Samir el Abdouni Integration of structure- and genomics- based screening to target immunological diseases 11. Marta Wells Structure-Based Discovery of Novel Glycinergic Modulators 12. Anthony R. Cillo Single cell RNAseq analysis of immune populations in patients with cancer 13. Gibran Biswas Using Computational Methods to Target the Immunoreceptor TIGIT 14. Abigail E Overacre-Delgoffe IFN-gamma drives Treg fragility to promote anti-tumor immunity 15. Hyokyeong Lee Cancer Immunotherapy: In search of pathways in metastatic melanoma using T-cell signature and anergy genes 16. Zoltan Oltavi Environment-induced transition from stochastic to spatially-ordered enzyme expression heterogeneity in cancer cell metabolism 17. Abstract withdrawn 18. Rebecca Elsner Salmonella enterica does not require Salmonella-specific B cells and is associated with blocked T follicular helper cell differentiation 19. Gabriele Farina Sequential Planning for Steering Immune System Adaptation 20. Amanda Clark A multi-organ microphysiological system that models dormantemergent metastatic breast cancer progression in a pharmacorelevant manner 21. Nicolas Pabon How PD-1 s flexible interface enables selective binding promiscuity 22. Jason Lohmueller msa2 biotin-binding CAR T cells for universal tumor targeting 7

8 23. Justin Spiriti Flexible Docking of Breast Cancer Drug Candidates to ER-α Using Mixed-Resolution Monte Carlo 24. Abstract Withdrawn 25. Sandra Cascio Validation of hypoglycosylated MUC1-CIN85 protein-protein interaction as a new therapeutic target for prevention of cancer invasion and metastasis 26. Jiyoung Lee Dynamics and ligand-binding properties of γ-secretase investigated by the Anisotropic Network Model and Molecular Simulations 27. Ashley Nelson ELL2 shifts gene expression by affecting alternative splicing in antibody secreting cells 28. Sanjana Gupta Dose discrimination in TNF-NFkB signaling 29. Lisa Borghesi Constructing a Human B Cell Atlas using Computational Flow Cytometry and Unsupervised Approaches 30. Weikang Wang Single Cell Segmentation with Deep Convolutional Neural Networks 31. Qiuhong Zhang Quantitative Single Cell Responses to Inflammatory Signals 32. Xueer Chen Systematic Study of Tumor-specific Immune Evasion Mechanisms 33. Xiaojun Tian Single Cell Segmentation with Deep Convolutional Neural Networks 34. Abstract withdrawn 35. Jocelyn Sunseri GPU Implementation of Molecular Docking with Receptor Flexibility 36. David Schipper Cellular responses to dynamic patterns of cytokine stimulation 8

Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School

Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Tumor Immunity and Immunotherapy Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Lecture Outline Evidence for tumor immunity Types of tumor antigens Generation of anti-tumor

More information

Emerging Tissue and Serum Markers

Emerging Tissue and Serum Markers Emerging Tissue and Serum Markers for Immune Checkpoint Inhibitors Kyong Hwa Park MD, PhD Medical Oncology Korea University College of Medicine Contents Immune checkpoint inhibitors in clinical practice

More information

International Society of Breast Pathology. Immune Targeting in Breast Cancer. USCAP 2017 Annual Meeting

International Society of Breast Pathology. Immune Targeting in Breast Cancer. USCAP 2017 Annual Meeting International Society of Breast Pathology USCAP 2017 Annual Meeting Immune Targeting in Breast Cancer Ashley Cimino-Mathews, MD Assistant Professor of Pathology and Oncology The Johns Hopkins Hospital

More information

Immunoreceptors and Immunotherapy

Immunoreceptors and Immunotherapy Immunoreceptors and Immunotherapy June 10-15, 2018 Snowmass, Colorado Co-Organizers: E. Sally Ward Texas A&M University Health Science Center Texas, USA Stephen A. Beers University of Southampton Southampton,

More information

Pathology of Inflammatory Breast Cancer (IBC) A rare tumor

Pathology of Inflammatory Breast Cancer (IBC) A rare tumor Pathology of Inflammatory Breast Cancer (IBC) A rare tumor Jelle Wesseling 1, John Martens 2, Gabe Sonke 1, Carolien Schröder 3 1: Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam

More information

Cancer immunity and immunotherapy. General principles

Cancer immunity and immunotherapy. General principles 1 Cancer immunity and immunotherapy Abul K. Abbas UCSF General principles 2 The immune system recognizes and reacts against cancers The immune response against tumors is often dominated by regulation or

More information

PD-L1 Expression and Signaling by Tumors and Macrophages: Comparative Studies in Mice and Dogs

PD-L1 Expression and Signaling by Tumors and Macrophages: Comparative Studies in Mice and Dogs PD-L1 Expression and Signaling by Tumors and Macrophages: Comparative Studies in Mice and Dogs Steven Dow, DVM, PhD Department of Clinical Sciences, Animal Cancer Center Colorado State University Consortium

More information

Molecular mechanisms of the T cellinflamed tumor microenvironment: Implications for cancer immunotherapy

Molecular mechanisms of the T cellinflamed tumor microenvironment: Implications for cancer immunotherapy Molecular mechanisms of the T cellinflamed tumor microenvironment: Implications for cancer immunotherapy Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader,

More information

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B 04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture

More information

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme 2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening

More information

BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION

BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION BASIC MECHANISM OF TUMOR IMMUNE SUPPRESSION Zihai Li, M.D., Ph.D. Leader, Cancer Immunology Program Hollings Cancer Center Medical University of South Carolina (MUSC) DISCLOSURE GOALS Understand that immune

More information

Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade

Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade Jun Wei Department of Neurosurgery October 23, 2009 Immune suppression in Malignant Glioma Patients Mechanisms

More information

Accepted Manuscript. Next Steps for Immune Checkpoints in Hepatocellular Carcinoma. Patricia M. Santos, Lisa H. Butterfield

Accepted Manuscript. Next Steps for Immune Checkpoints in Hepatocellular Carcinoma. Patricia M. Santos, Lisa H. Butterfield Accepted Manuscript Next Steps for Immune Checkpoints in Hepatocellular Carcinoma Patricia M. Santos, Lisa H. Butterfield PII: S0016-5085(18)35218-1 DOI: https://doi.org/10.1053/j.gastro.2018.11.008 Reference:

More information

Therapeutic efficacy of MUC1- specific CTL and CD137 costimulation. mammary cancer model. Pinku Mukherjee & Sandra Gendler

Therapeutic efficacy of MUC1- specific CTL and CD137 costimulation. mammary cancer model. Pinku Mukherjee & Sandra Gendler Therapeutic efficacy of MUC1- specific CTL and CD137 costimulation in a spontaneous mammary cancer model Pinku Mukherjee & Sandra Gendler Goal of Immunotherapy Boosting the low level anti-tumor immune

More information

5% of patients with genetic immunodeficiency develop a cancer during their lifetime (200x)

5% of patients with genetic immunodeficiency develop a cancer during their lifetime (200x) Immune surveillance 5% of patients with genetic immunodeficiency develop a cancer during their lifetime (200x) Transplanted patients following an immunosuppressor therapy are 80 times more likely to develop

More information

2018 III Initiative Symposium 2 P a g e

2018 III Initiative Symposium 2 P a g e 2018 III Initiative Symposium 2 Accreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical

More information

Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning

Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning Yi-Hsiang Hsu, MD, SCD Sep 16, 2017 yihsianghsu@hsl.harvard.edu Director & Associate

More information

Immunogenomics of disease: accelerating to patient benefit. Conference Programme

Immunogenomics of disease: accelerating to patient benefit. Conference Programme Immunogenomics of disease: accelerating to patient benefit Wellcome Genome Camps Conference Centre, Hinxton, Cambridge 6-8 February 2017 Lectures to be held in the Francis Crick Auditorium Lunch and dinner

More information

Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning

Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning Immuno-Oncology Therapies and Precision Medicine: Personal Tumor-Specific Neoantigen Prediction by Machine Learning Yi-Hsiang Hsu, MD, SCD Sep 16, 2017 yihsianghsu@hsl.harvard.edu HSL GeneticEpi Center,

More information

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 Tumor Immunology M. Nagarkatti Teaching Objectives: Introduction to Cancer Immunology Know the antigens expressed by cancer cells Understand

More information

Highlights from AACR 2015: The Emerging Potential of Immunotherapeutic Approaches in Non-Small Cell Lung Cancer

Highlights from AACR 2015: The Emerging Potential of Immunotherapeutic Approaches in Non-Small Cell Lung Cancer Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Tim-3 as a target for tumor immunotherapy

Tim-3 as a target for tumor immunotherapy Tim-3 as a target for tumor immunotherapy Ana Carrizosa Anderson Brigham and Women s Hospital Harvard Medical School Disclosures A portion of the work has been performed as part of a sponsored research

More information

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline 1 T Lymphocyte Activation and Costimulation Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline T cell activation Costimulation, the B7:CD28 family Inhibitory receptors of T cells Targeting costimulators for

More information

2019 Missouri GIS Conference

2019 Missouri GIS Conference 2019 Missouri GIS Conference 2019 Missouri GIS Conference April 29 May 1, 2019 Detailed conference information including the schedule, presentation descriptions, exhibitors and more can be found on the

More information

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes

More information

Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain

Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo

More information

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust IMMUNOTHERAPY FOR CANCER A NEW HORIZON Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust ASCO Names Advance of the Year: Cancer Immunotherapy No recent

More information

CONCURRENT SESSION 1. HUMAN CANCER IMMUNOBIOLOGY Chairs: David Klinke, PhD and Todd Schell, PhD

CONCURRENT SESSION 1. HUMAN CANCER IMMUNOBIOLOGY Chairs: David Klinke, PhD and Todd Schell, PhD CONCURRENT SESSION 1. HUMAN CANCER IMMUNOBIOLOGY Chairs: David Klinke, PhD and Todd Schell, PhD Abstract #1: Christopher A. Chuckran Neuropilin-1 stabilizes human Tregs in cancer patients potentiating

More information

Houston January 27, 2018

Houston January 27, 2018 Houston January 27, 2018 Brian Brewer Cancer Research Institute WELCOME Our Host A special thank you for hosting the Immunotherapy Patient Summit Our Sponsors This event is made possible with generous

More information

Understanding and overcoming immunoregulatory barriers within

Understanding and overcoming immunoregulatory barriers within Understanding and overcoming immunoregulatory barriers within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader, Immunology and

More information

presents October 2 nd 6 th, 2008 Salishan Resort, Gleneden Beach, Oregon K E Y N O T E S E S S I O N

presents October 2 nd 6 th, 2008 Salishan Resort, Gleneden Beach, Oregon K E Y N O T E S E S S I O N The 57 th annual Montagna Symposium on the Biology of Skin presents The Biologic Basis of Psoriasis October 2 nd 6 th, 2008 Salishan Resort, Gleneden Beach, Oregon Program Chairs Andrew Blauvelt, MD Anne

More information

Immune surveillance hypothesis (Macfarlane Burnet, 1950s)

Immune surveillance hypothesis (Macfarlane Burnet, 1950s) TUMOR-IMMUNITÄT A.K. Abbas, A.H. Lichtman, S. Pillai (6th edition, 2007) Cellular and Molecular Immunology Saunders Elsevier Chapter 17, immunity to tumors Immune surveillance hypothesis (Macfarlane Burnet,

More information

Thursday 02 February 2017

Thursday 02 February 2017 Programme Thursday 02 February 2017 12:00-13:30 Arrival / Registration with light refreshments ATC Reception and Foyer 13:30-13:45 Opening remarks 13:45-17:30 Session 1: Unleashing endogenous immunity

More information

Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates

Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates Christopher Turner, MD Vice President, Clinical Science 04 November 2016 Uveal Melanoma Celldex Pipeline CANDIDATE INDICATION Preclinical

More information

Bayesian Inference for Single-cell ClUstering and ImpuTing (BISCUIT) Elham Azizi

Bayesian Inference for Single-cell ClUstering and ImpuTing (BISCUIT) Elham Azizi Bayesian Inference for Single-cell ClUstering and ImpuTing (BISCUIT) Elham Azizi BioC 2017: Where Software and Biology Connect Profiling Tumor-Immune Ecosystem in Breast Cancer Immunotherapy treatments

More information

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich

Immune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Immune Checkpoints PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Activation of T cells requires co-stimulation Science 3

More information

Welcome. Nanostring Immuno-Oncology Summit. September 21st, FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Welcome. Nanostring Immuno-Oncology Summit. September 21st, FOR RESEARCH USE ONLY. Not for use in diagnostic procedures. Welcome Nanostring Immuno-Oncology Summit September 21st, 2017 1 FOR RESEARCH USE ONLY. Not for use in diagnostic procedures. FOR RESEARCH USE ONLY. Not for use in diagnostic procedures. Agenda 4:00-4:30

More information

Novel RORg Agonists Enhance Anti-Tumor Activity of Adoptive T Cell Therapy

Novel RORg Agonists Enhance Anti-Tumor Activity of Adoptive T Cell Therapy Novel RORg Agonists Enhance Anti-Tumor Activity of Adoptive T Cell Therapy Jacques Moisan, Kinga Majchrzak, Xiao Hu, Rodney Morgan, Xikui Liu, Kellie Demock, Yahong Wang, Charles Lesch, Brian Sanchez,

More information

T cell maturation. T-cell Maturation. What allows T cell maturation?

T cell maturation. T-cell Maturation. What allows T cell maturation? T-cell Maturation What allows T cell maturation? Direct contact with thymic epithelial cells Influence of thymic hormones Growth factors (cytokines, CSF) T cell maturation T cell progenitor DN DP SP 2ry

More information

L1 on PyMT tumor cells but Py117 cells are more responsive to IFN-γ. (A) Flow

L1 on PyMT tumor cells but Py117 cells are more responsive to IFN-γ. (A) Flow A MHCI B PD-L1 Fold expression 8 6 4 2 Fold expression 3 2 1 No tx 1Gy 2Gy IFN Py117 Py117 Supplementary Figure 1. Radiation and IFN-γ enhance MHCI expression and PD- L1 on PyMT tumor cells but Py117 cells

More information

Tumor Microenvironment and Immune Suppression

Tumor Microenvironment and Immune Suppression Tumor Microenvironment and Immune Suppression Hassane M. Zarour,, MD Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Cancer Institute Hallmarks of Cancer: The Next Generation

More information

Identification of novel immune regulators of tumor growth using highthroughput

Identification of novel immune regulators of tumor growth using highthroughput Identification of novel immune regulators of tumor growth using highthroughput screening in vivo Tom Brennan 1 Five Prime s Unique Platform Tests Nearly Every Extracellular Protein to Identify Protein

More information

Disclosure Information. Mary L. Disis

Disclosure Information. Mary L. Disis Disclosure Information Mary L. Disis I have the following financial relationships to disclose: Consultant for: VentiRx, Celgene, Emergent, EMD Serono Speaker s Bureau for: N/A Grant/Research support from:

More information

The Challenge of Chronic Pain 4-6 March Wellcome Genome Campus, Hinxton, Cambridge, UK

The Challenge of Chronic Pain 4-6 March Wellcome Genome Campus, Hinxton, Cambridge, UK The Challenge of Chronic Pain 4-6 March 2019 Wellcome Genome Campus, Hinxton, Cambridge, UK Lectures to be held in the Francis Crick Auditorium Lunch and dinner to be held in the Hall Restaurant Poster

More information

How Systems Biology Can Advance Immune Oncology. Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st

How Systems Biology Can Advance Immune Oncology. Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st How Systems Biology Can Advance Immune Oncology Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st Immuno-Oncology is One of the Most Promising Avenues in the Battle Against Cancer Conventional Therapy

More information

Evaluation of the Tumor Microenvironment. Mark Headley University of California, San Francisco SITC 2016

Evaluation of the Tumor Microenvironment. Mark Headley University of California, San Francisco SITC 2016 Evaluation of the Tumor Microenvironment Mark Headley University of California, San Francisco SITC 2016 Presenter Disclosure Information Mark B. Headley, PhD In addition to appointment at UCSF Joint position

More information

Restoring Immune Function of Tumor-Specific CD4 + T Cells during Recurrence of Melanoma

Restoring Immune Function of Tumor-Specific CD4 + T Cells during Recurrence of Melanoma Restoring Immune Function of Tumor-Specific CD4 + T Cells during Recurrence of Melanoma Goding SR et al. J Immunol 2013; 190:4899-4909 C. Nikolowsky Christian Doppler Laboratory for Cardiac and Thoracic

More information

2018: HORIZONS OF CANCER BIOLOGY AND THERAPY

2018: HORIZONS OF CANCER BIOLOGY AND THERAPY 2018: HORIZONS OF CANCER BIOLOGY AND THERAPY Day 1: Saturday September 08, 2018 Session 1: Opening Session 17:00-17:30 Charles Sawyers - New York, USA Drug Resistance in Cancer 17:30-18:00 Lisa Coussens

More information

Ludwig Presence at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Ludwig Presence at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting Ludwig Scientist(s) Affiliation(s) Keywords Abstract/Presentation Category Presentation/Abstract Title & Time FRIDAY, NOVEMBER 10 Arlene Sharpe (session chair) Ludwig Harvard N/A Science Behind the Therapy:

More information

Cancer Biology Annual Retreat

Cancer Biology Annual Retreat Cancer Biology Annual Retreat Kiawah Island, South Carolina October 25-27, 2015 Agenda Sunday, October 25 9:00 am 12:00 pm Executive Committee/Board Meeting 2:00 pm 7:00 pm Welcome Lounge & Registration

More information

Program 12 th Meeting of the IBCN September th, 2014, Vancouver, Canada

Program 12 th Meeting of the IBCN September th, 2014, Vancouver, Canada THURSDAY, SEPTEMBER 25 TH, 2014 19.00 Welcome Dinner Cactus Club, Yaletown (357 Davie St) FRIDAY, SEPTEMBER 26 TH, 2014 Introduction Topic Speaker 07:30 08:00 Registration/Light breakfast 08:00 08:15 Welcome

More information

Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game?

Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game? Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game? Sylvie NEGRIER MD, PhD Centre Léon Bérard, Lyon Université Lyon I IMMUNOTHERAPY: A LONG AND WIDING ROAD! WHERE

More information

SEVENTH ANNUAL NEUROSCIENCE, BEHAVIOR AND HEALTH RESEARCH FORUM

SEVENTH ANNUAL NEUROSCIENCE, BEHAVIOR AND HEALTH RESEARCH FORUM SEVENTH ANNUAL NEUROSCIENCE, BEHAVIOR AND HEALTH RESEARCH FORUM Image: James Bishop The University of Vermont Dudley H Davis Center Grand Maple Ballroom January 20-21, 2017 Sponsored by: University of

More information

Radiation and Immunotherapy

Radiation and Immunotherapy Radiation and Immunotherapy What s it All About? Encouse Golden, MD, PhD Assistant Professor of Radiation Oncology 10.25.16 www.weillcornell.org Silvia Formenti, MD Chairman of Radiation Oncology, Sandra

More information

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President

More information

Darwinian selection and Newtonian physics wrapped up in systems biology

Darwinian selection and Newtonian physics wrapped up in systems biology Darwinian selection and Newtonian physics wrapped up in systems biology Concept published in 1957* by Macfarland Burnet (1960 Nobel Laureate for the theory of induced immune tolerance, leading to solid

More information

SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II

SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II THURSDAY, SEPTEMBER 27 1200-1800 REGISTRATION Ballroom Foyer 1330-1430 WELCOME AND OPENING KEYNOTE LECTURE 1330-1340 Welcome from Scientific Committee Cochairs Carlos L. Arteaga, UT Southwestern Simmons

More information

T Cell Activation, Costimulation and Regulation

T Cell Activation, Costimulation and Regulation 1 T Cell Activation, Costimulation and Regulation Abul K. Abbas, MD University of California San Francisco 2 Lecture outline T cell antigen recognition and activation Costimulation, the B7:CD28 family

More information

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology

Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology Immune Cell Phenotyping in Solid Tumors using Quantitative Pathology James R. Mansfield Director of Quantitative Pathology Applications 2009 PerkinElmer What is Quantitative Pathology? Quantitative Pathology

More information

Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D.

Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader,

More information

Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party

Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party TIMETABLE Plenary Workshop Special Breaks Optional Event Educational Meet the expert INGID Working Party Wednesday 24 October 2018 I 08:30-09:00 Educational Lecture - Lymphoproliferation in PIDs 09:00-09:30

More information

Allergy and Immunology Review Corner: Chapter 19 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Allergy and Immunology Review Corner: Chapter 19 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Allergy and Immunology Review Corner: Chapter 19 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Chapter 19: Tolerance, Autoimmunity, and Autoinflammation Prepared

More information

Posters and Presentations

Posters and Presentations Posters and Presentations June 2017: American Society of Clinical Oncology (ASCO) Annual - Preliminary Correlative Analysis of PD-L1 expression from the SUNRISE Study. View April 2017: American Association

More information

Tumor Immunology. Wirsma Arif Harahap Surgical Oncology Consultant

Tumor Immunology. Wirsma Arif Harahap Surgical Oncology Consultant Tumor Immunology Wirsma Arif Harahap Surgical Oncology Consultant 1) Immune responses that develop to cancer cells 2) Escape of cancer cells 3) Therapies: clinical and experimental Cancer cells can be

More information

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells

More information

Neuroscience Day 2013

Neuroscience Day 2013 INNSBRUCK MEDICAL UNIVERSITY & UNIVERSITY OF INNSBRUCK - NEUROSCIENCE Neuroscience Day 2013 Friday, April 5 th 2013, Innsbruck, Innrain 80/82 - CCB Final Program & Abstract Book Scientific program Friday,

More information

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre No Disclosures

More information

FOCiS. Lecture outline. The immunological equilibrium: balancing lymphocyte activation and control. Immunological tolerance and immune regulation -- 1

FOCiS. Lecture outline. The immunological equilibrium: balancing lymphocyte activation and control. Immunological tolerance and immune regulation -- 1 1 Immunological tolerance and immune regulation -- 1 Abul K. Abbas UCSF FOCiS 2 Lecture outline Principles of immune regulation Self-tolerance; mechanisms of central and peripheral tolerance Inhibitory

More information

Emerging Targets in Immunotherapy

Emerging Targets in Immunotherapy Emerging Targets in Immunotherapy So Jin Shin, M.D. Department of Obstetrics and Gynecology, Keimyung University, School of Medicine, Daegu, Korea no-0ncology Todays is.. ancer Immunotherapy? nd immunotherapy

More information

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells Andrew H. Lichtman, M.D. Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard

More information

Cell-mediated Immunity

Cell-mediated Immunity Cellular & Molecular Immunology Cell-mediated Immunity Nicholas M. Ponzio, Ph.D. Department of Pathology & Laboratory Medicine April 6, 2009 Today s Presentation: Overview Cellular Interactions In Humoral

More information

Biomarker integration in clinical trials for immunotherapies

Biomarker integration in clinical trials for immunotherapies Biomarker integration in clinical trials for immunotherapies Lisa H. Butterfield, Ph.D. Professor of Medicine, Surgery and Immunology University of Pittsburgh Cancer Institute Director, UPCI Immunologic

More information

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center General Overview of Immunology Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center Objectives Describe differences between innate and adaptive immune responses

More information

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly

More information

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes: Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,

More information

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes: Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,

More information

Bum-Sup Jang and In Ah Kim. ¹Department of Radiation Oncology, Seoul National University Graduate School of Medicine 2

Bum-Sup Jang and In Ah Kim. ¹Department of Radiation Oncology, Seoul National University Graduate School of Medicine 2 A Radiosensitivity Gene Signature and PD-L1 Predict Clinical Outcome of Patients with Invasive Breast Carcinoma in The Cancer Genome Atlas (TCGA) Dataset Bum-Sup Jang and In Ah Kim ¹Department of Radiation

More information

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated

More information

Retreat Program Friday, Nov. 15, 2013

Retreat Program Friday, Nov. 15, 2013 Retreat Program Friday, Nov. 15, 2013 9:15 a.m. Noon (Closed session) Noon 1 p.m. Mentoring, Education & Training Panel Lari Wenzel, PhD Lunch @ the Atrium Session I The Grand Salon 1 1:10 p.m. Welcome

More information

Immunotherapy: The Newest Treatment Route

Immunotherapy: The Newest Treatment Route Immunotherapy: The Newest Treatment Route IWMF Patient Forum, Phoenix, AZ Madhav Dhodapkar, MD Professor of Medicine and Immunobiology Chief, Section of Hematology Yale University or the Oldest William

More information

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Chapter 13: Mechanisms of Immunity to Viral Disease Prepared by

More information

The Immune System. Innate. Adaptive. - skin, mucosal barriers - complement - neutrophils, NK cells, mast cells, basophils, eosinophils

The Immune System. Innate. Adaptive. - skin, mucosal barriers - complement - neutrophils, NK cells, mast cells, basophils, eosinophils Objectives - explain the rationale behind cellular adoptive immunotherapy - describe methods of improving cellular adoptive immunotherapy - identify mechanisms of tumor escape from cellular adoptive immunotherapy

More information

Deciphering the biology that drives response to immunotherapy

Deciphering the biology that drives response to immunotherapy Deciphering the biology that drives response to immunotherapy Phenoptics TM Quantitative Pathology Platform Trent Norris, Field Application Scientist September 15, 2016 HUMAN HEALTH ENVIRONMENTAL HEALTH

More information

RXi Pharmaceuticals. Immuno-Oncology World Frontiers Conference. January 23, 2018 NASDAQ: RXII. Property of RXi Pharmaceuticals

RXi Pharmaceuticals. Immuno-Oncology World Frontiers Conference. January 23, 2018 NASDAQ: RXII. Property of RXi Pharmaceuticals RXi Pharmaceuticals Immuno-Oncology World Frontiers Conference January 23, 2018 NASDAQ: RXII Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private

More information

Cancer Biometrics: Results of the 2003 isbtc Workshop. Theresa L. Whiteside, Ph.D., ABMLI University of Pittsburgh Cancer Institute

Cancer Biometrics: Results of the 2003 isbtc Workshop. Theresa L. Whiteside, Ph.D., ABMLI University of Pittsburgh Cancer Institute Cancer Biometrics: Results of the 2003 isbtc Workshop Theresa L. Whiteside, Ph.D., ABMLI University of Pittsburgh Cancer Institute The workshop objective The objective was to consider state-of-theart approaches

More information

T-cell Exhaustion in Leukemia Relapse Post Allogeneic Stem Cell Transplantation

T-cell Exhaustion in Leukemia Relapse Post Allogeneic Stem Cell Transplantation T-cell Exhaustion in Leukemia Relapse Post Allogeneic Stem Cell Transplantation Hong Zheng, M.D., Ph.D. Assistant Professor of Medicine Penn State Hershey Cancer Institute Penn State University College

More information

Developing Novel Immunotherapeutic Cancer Treatments for Clinical Use

Developing Novel Immunotherapeutic Cancer Treatments for Clinical Use Developing Novel Immunotherapeutic Cancer Treatments for Clinical Use Oncology for Scientists March 8 th, 2016 Jason Muhitch, PhD Assistant Professor Department of Urology Email: jason.muhitch@roswellpark.org

More information

Getting the Whole Picture for Immuno-Oncology Therapies

Getting the Whole Picture for Immuno-Oncology Therapies Joseph Krueger, Chief Scientific Officer, Flagship Biosciences, Inc. Getting the Whole Picture for Immuno-Oncology Therapies Key concepts: Immuno-oncology (IO) therapies have changed the way we think about

More information

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION What is Cytokine? Secreted popypeptide (protein) involved in cell-to-cell signaling. Acts in paracrine or autocrine fashion through specific cellular receptors.

More information

Predicting outcome from cancer data

Predicting outcome from cancer data Predicting outcome from cancer data Jeffrey Chuang The Jackson Laboratory for Genomic Medicine Drowning in data, thirsting for knowledge 2 Clinical outcome across cancer types TCGA Cancer types 5-year

More information

Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA

Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing

More information

Radiation Therapy as an Immunomodulator

Radiation Therapy as an Immunomodulator Radiation Therapy as an Immunomodulator Yvonne Mowery, MD, PhD February 20, 2017 Tumor/Immune System Balance Kalbasi, JCI 2013 UNC-Duke-NC State-Wake Forest Spring 2017 2 RT Can Shift Balance Toward Elimination

More information

Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression

Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression Jarad J Wilson, Ph.D. Technical Support & Marketing Specialist Ruo-Pan Huang, MD, Ph.D. Founder and CEO What are Antibody Arrays?

More information

Pursuing Novel Pathways in Immunology: Merck KGaA, Darmstadt, Germany Presents New Clinical Data at 2017 ACR/ARHP Annual Meeting

Pursuing Novel Pathways in Immunology: Merck KGaA, Darmstadt, Germany Presents New Clinical Data at 2017 ACR/ARHP Annual Meeting News Release Your Contact Brenda Mulligan +1 (978) 821-5345 October 20, 2017 ACR Abstract # Atacicept: 889, 2585, 2586, 2610; Sprifermin: 1207, 2183, 1L; Abituzumab: 774; Evobrutinib: 2565; Discovery Products:

More information

ImmunoTools special Award 2014

ImmunoTools special Award 2014 ImmunoTools special Award 2014 Davide Ferrari, PhD University of Ferrara, Department of Morphology, Surgery and Experimental Medicine. Section of Pathology, Oncology and Exper. Biology via L. Borsari 46,

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

CELLULAR AND MOLECULAR REQUIREMENTS FOR REJECTION OF B16 MELANOMA IN THE SETTING OF REGULATORY T CELL DEPLETION AND HOMEOSTATIC PROLIFERATION

CELLULAR AND MOLECULAR REQUIREMENTS FOR REJECTION OF B16 MELANOMA IN THE SETTING OF REGULATORY T CELL DEPLETION AND HOMEOSTATIC PROLIFERATION CELLULAR AND MOLECULAR REQUIREMENTS FOR REJECTION OF B16 MELANOMA IN THE SETTING OF REGULATORY T CELL DEPLETION AND HOMEOSTATIC PROLIFERATION Justin Kline 1, Long Zhang 1, and Thomas F. Gajewski 1,2 Departments

More information

TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL)

TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL) KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 28, 2017

More information

Biomarkers in Imunotherapy: RNA Signatures as predictive biomarker

Biomarkers in Imunotherapy: RNA Signatures as predictive biomarker Biomarkers in Imunotherapy: RNA Signatures as predictive biomarker Joan Carles, MD PhD Director GU, CNS and Sarcoma Program Department of Medical Oncology Vall d'hebron University Hospital Outline Introduction

More information